📸 Highlights from Axtria Poster Presentations at ISPOR—The Professional Society for Health Economics and Outcomes Research 2026 At this year’s ISPOR, Axtria teams presented a diverse portfolio of research across key themes shaping the future of healthcare: 🔹 Real‑world evidence in regulatory and clinical decision‑making 🔹 Social determinants of health and their impact on outcomes 🔹 AI‑driven approaches to evidence generation 🔹 Market and treatment insights across therapeutic areas Each poster sparked valuable dialogue with global stakeholders focused on advancing value, access, and patient outcomes. Across sessions, posters, and hallway conversations, a few themes consistently stood out: 💡 MFN pricing dominated policy discussions, raising important questions on balancing innovation and access 💡 Target Trial Emulation is moving from methodology to expectation, with external control arms (ECA) front and center 💡 AI in HEOR is no longer aspirational it’s actively reshaping SLR and RWE workflows, with governance frameworks catching up 💡 Cell and gene therapies are pushing RWE deeper into regulatory and reimbursement conversations 💡 Whole health is emerging as a unifying theme bringing equity, SDoH, and societal value into sharper focus Take a look at moments captured from across our poster sessions. Learn more: https://lnkd.in/eVDBJxvx Rachel Gamburg, Coby Martin Navneet Kumar, Ph.D., HARSHIT DIXIT Zhouyang Lou, Ph.D, HARSHIT DIXIT, Jared Miller, Jatinder Kumar, Vishnu Bharadwaj Suresh, Ruihong (Heather) Wang, Sabrina Gaiazov #ISPOR2026 #HEORCommunity #EvidenceBasedHealthcare #HealthInnovation
-
-
-
-
-
+2